SCHEMBL23957955

SCHEMBL23957955

CC(C)(C)c1cn(C(C)(C)C)c(=O)c2cnccc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 1/20 0.34
BRD4 O60885 7/20 0.33
BRD9 Q9H8M2 3/20 0.33
BRD7 Q9NPI1 3/20 0.33
TAF1 P21675 2/20 0.33
TGFBR1 P36897 2/20 0.33
ACVR1 Q04771 2/20 0.33
CREBBP Q92793 2/20 0.33
CECR2 Q9BXF3 2/20 0.33
BRPF1 P55201 1/20 0.33
BPTF Q12830 1/20 0.33
TAF1L Q8IZX4 1/20 0.33
BAZ2B Q9UIF8 1/20 0.33
ATAD2B Q9ULI0 1/20 0.33
KAT2B Q92831 2/20 0.33
FEN1 P39748 1/20 0.33
CYP2D6 P10635 1/20 0.32
ACVR2B Q13705 1/20 0.32
BRD8 Q9H0E9 1/20 0.32
ADORA3 P0DMS8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23957951 0.94 BRD4 (0.35) KDM5ABRD4BRD9BRD7TAF1
SCHEMBL19869619 0.83 BRD4 (0.44) BRD4BRD9BRD7TAF1TGFBR1
SCHEMBL23957953 0.78 BRD4 (0.37) BRD4BRD9BRD7TDP1
SCHEMBL19869985 0.76 BRD4 (0.46) BRD4BRD9BRD7TAF1TGFBR1
SCHEMBL18350677 0.72 KIF11 (0.35) KAT2BCYP2D6IDO1NFATC1GSK3B
SCHEMBL28948256 0.71 HTR2A (0.38) KDM5AFEN1IDO1DYRK1A
SCHEMBL30171226 0.71 HTR2A (0.38) KDM5AFEN1IDO1DYRK1A
SCHEMBL23957954 0.71 NPC1 (0.37) BRD4KAT2BFEN1
SCHEMBL23957952 0.71 NPC1 (0.37) BRD4KAT2BFEN1PARP1
SCHEMBL21363431 0.70 KDM4C (0.42) KDM5AIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210330646-A1 FASCIN BINDING COMPOUNDS FOR SPINOGENESIS SPINOGENIX, INC. 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210330646-A1 FASCIN BINDING COMPOUNDS FOR SPINOGENESIS FSCN1, SMN1; SMN2, DCX KDM5A 4210/4885BRD4 1546/4885BRD9 4425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.